A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesGenetic abnormalities in pancreatic cancerPancreatic endocrine neoplasms: a current update on genetics and imaging.Chromosome 3p alterations in pancreatic endocrine neoplasiaReview of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms.Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridizationPutative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progressionPancreatic neuroendocrine tumors: biology, diagnosis,and treatmentManagement challenges in a child with hyperinsulinemic hypoglycemia.Role of everolimus in pancreatic neuroendocrine tumors.Sunitinib in pancreatic neuroendocrine tumors.Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.Role of disease-causing genes in sporadic pancreatic endocrine tumors:MEN1andVHL
P2860
Q24647838-3F277E5F-111A-40A4-A6F1-B993BE4200CDQ24800194-E6572B2D-0D60-4AB5-B4F5-83750B0F25D6Q26852418-016449B8-4A4E-42C3-B608-25DB9840095EQ34467655-51C0D2DB-CCD4-46BC-98CA-B324EED14DD0Q34810946-BFBBF5F3-DAFC-4C5B-9AFF-3237023F1A40Q35746144-A01252C4-C0DC-4524-B798-1560FA7B2F25Q35787979-6632FA54-F254-472C-88F0-9040820AC8F2Q35842229-D6865D4E-2207-4B06-BCC9-2FAC3E9F7D8EQ36549465-48F51D3C-8C37-492A-B592-86EF8DDAAE6EQ36615803-4F1615E6-C196-455A-B675-8A9DDA223E87Q37354131-4D7F15FB-8FE6-4604-A47F-FDF2D5B739E7Q37732724-B6A462ED-944D-40B8-BF87-8CE7850ED7B5Q37935772-72B50D4F-C0BC-4096-BF97-2DE6E9163948Q38015764-77658D47-589B-4CF9-B157-71A3E8BBA497Q47615275-34DA72E6-E026-4C22-8A65-3F0EF3516B15Q54661904-296D5775-A98F-47A1-A146-C9ED78F734E0Q57290138-881D493E-E5EA-462E-BC77-C33D27B67EC0
P2860
A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel pancreatic endocrine t ...... inical prognostic implications
@en
A novel pancreatic endocrine t ...... nical prognostic implications.
@nl
type
label
A novel pancreatic endocrine t ...... inical prognostic implications
@en
A novel pancreatic endocrine t ...... nical prognostic implications.
@nl
prefLabel
A novel pancreatic endocrine t ...... inical prognostic implications
@en
A novel pancreatic endocrine t ...... nical prognostic implications.
@nl
P2093
P2860
P356
P1476
A novel pancreatic endocrine t ...... inical prognostic implications
@en
P2093
A L Warshaw
F Graeme-Cook
P2860
P304
P356
10.1172/JCI119547
P407
P577
1997-07-01T00:00:00Z